Phanères complex
Food supplement declared in France
Phanères complex is a food supplement declared in France. Status: retiré du marché le 30 September 2026. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- LAB. O2&VIE SAS
- Status
- Retiré du marché le 30 September 2026
- Form
- Gélule
- Daily dose
- Prendre 1 gélule par jour
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans), Femmes allaitantes, Femmes enceintes
Declaration 342113, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retiré du marché le 30 September 2026, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Substances
| Name | Per day |
|---|---|
| acétylcystéine | 100 mg |
| glycine | 75 mg |
| proline | 74 mg |
| hydroxyproline | 24 mg |
| glutathion | 20 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Chlorhydrate de lysine | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Sélénite de sodium | Sélénium | 255 µg | 50 µg |
| Acide L-ascorbique | Vitamine C | pas de limite (données insuffisantes) | 180 mg |
Additives
E464
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Réservé aux adultes. Les femmes enceintes et allaitantes sont invitées à prendre l’attache d’un professionnel de santé avant toute supplémentation
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.